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Abstract
Introduction: Doxycycline-induced esophageal ulcer patients are mostly young persons with no
history of esophageal dysfunction. Heartburn, midsternal pain and dysphagia are the most common
symptoms. It has generally a benign course. The present case is the first report of doxycycline-
induced extensive ulcerations, mimicking esophageal cancer in two esophageal segments alongside,
in the literature.
Case presentation: This report describes a 16-year-old Caucasian girl who, while taking
doxycycline capsules100 mg twice a day for acne vulgaris for 3 months, developed these symptoms.
An upper endoscopy revealed multiple circumferential deep ulcerations surrounding fragile,
irregular, hyperemic and hypertrophic mucosa at the level of the mid-esophagus and concomitantly
in the lower esophageal sphincter. The lesions were biopsied to exclude esophageal carcinoma
because of the suspicious appearance in the endoscopic examination. The histopathological
examination, haematoxylin and eosin stained sections showed ulceration with a mixed
inflammatory infiltrate. Doxycycline was discontinued and she was given sucralfate 1 g qid and
omeprazole 20 mg bid orally. All symptoms of the patient were resolved on the third day of the
treatment. After 4 weeks of the therapy, an upper endoscopic control examination demonstrated
normal findings.
Conclusion:  The present case has been an uncommon presentation of doxycycline-induced
extensive ulcerations, mimicking esophageal cancer in two esophageal segments, concomitantly.
Even the lesions were biopsied to exclude esophageal carcinoma. A modification on the behavior
of taking drugs can prevent these unpleasant complications.
Introduction
Doxycycline-induced esophageal lesions had been exam-
ined mostly as mild esophagitis and sometimes as ulcera-
tion with a generally benign course. Common reason of
this complication has been taking medications just before
bedtime, and with a small amount of water [1,2]. In gen-
eral the certain drugs tend to cause the damage in a singu-
lar segment, as doxycycline in mid-esophageal segment
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[3]. Here we present a severe, unusual endoscopic appear-
ance of a case of doxycycline-induced esophageal ulcers
and tissue fragility mimicking esophageal cancer in the
lower and mid-esophageal segments, simultaneously.
Case report
A 16-year-old Caucasian girl was admitted to our outpa-
tient clinic with complains of heartburn, midsternal pain
and dysphagia for 4 weeks. She had no fever, cough or any
additional complain. Her cardiac and chest auscultation
and throat examination were normal. Her whole blood
count and erythrocyte sedimentation rate were also nor-
mal. Her electrocardiography and chest x-ray revealed no
pathological findings. An upper endoscopy revealed mul-
tiple circumferential deep ulcerations surrounding fragile,
irregular, hyperemic and hypertrophic mucosa at the level
of the mid-esophagus (Figure 1) and lower esophageal
sphincter (Figure 2). Because of the suspicious endoscopic
appearance, the lesions were biopsied to exclude esopha-
geal carcinoma. In her detailed history, she was taking
doxycycline capsules 100 mg twice a day for acne vulgaris
for 3 months. She was swallowing only the capsule in the
recumbent position at midnight. In the histopathological
examination, haematoxylin and eosin stained sections
showed ulceration with a mixed inflammatory infiltrate
(Figure 3). Doxycycline was discontinued and she was
given sucralfate 1 g qid and omeprazole 20 mg bid orally
to control of gastric acid reflux until her symptoms
resolve. All symptoms of the patient were dramatically
resolved on the third day of the treatment. A control
endoscopy demonstrated normal findings, after 4 weeks
of the therapy.
Discussion
Drug-induced ulcer is thought not to be so common;
however it is not an unusual clinical condition especially
in patients taking certain drugs. Doxycycline-induced
esophageal ulcer patients are mostly young persons with
no history of esophageal dysfunction. The main reason for
an increased transit time is to take the medication with a
small amount of water immediately before sleeping, as
the present case did [1,2]. Drug-induced esophagitis is
more frequent with capsule than with tablet, because of its
easier adhesion to the esophageal surface [4]. As an acidic
Endoscopic appearance of the ulcers mimicking cancer at the  level of the mid-esophagus Figure 1
Endoscopic appearance of the ulcers mimicking can-
cer at the level of the mid-esophagus. An upper endo-
scopic examination revealed multiple circumferential deep 
ulcerations surrounding fragile, irregular, hyperemic and 
hypertrophic mucosa at the level of the mid-esophagus.
Endoscopic appearance of the ulcers mimicking cancer in the  lower esophageal sphincter Figure 2
Endoscopic appearance of the ulcers mimicking can-
cer in the lower esophageal sphincter. Same endoscopic 
findings of the mid-esophagus were observed in the lower 
esophageal sphincter.
Histopathological section of the ulcer tissue Figure 3
Histopathological section of the ulcer tissue. His-
topathological section of the ulcer tissue showed ulceration 
with a mixed inflammatory infiltrate (HE, × 100).Publish with BioMed Central    and   every 
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drug, doxycycline accumulation in the epithelial cells can
also cause a focal contact esophagitis. With its subsequent
local cytochemical effects, doxycycline can cause ulcera-
tion and friability of the adjacent esophageal mucosa. In
addition, doxycycline can also inhibit protein synthesis
functions in the esophagus [5,6].
Nevertheless history and upper endoscopy can confirm
the diagnosis in almost all cases. In suspected conditions,
exclusion of esophageal carcinoma by histology can be
necessary [2], as it was the case in our patient.
Gencosmanoglu et al. revealed that tetracycline tends to
cause distal esophagitis and doxycycline is more fre-
quently associated with mid-esophageal ulceration [3].
However, in the present case, we identified doxycycline-
induced ulcers in both distal and mid-esophageal locali-
zations. Drug-induced esophagitis should be suspected in
all patients presenting with chest pain and dysphagia and
is a preventable cause of morbidity that consists of giving
simple advice of how and when to take medication. The
prevention could be achieved by swallowing the drug
with at least 100 ml of water after swallowing the medica-
tion and remaining in the upright position thereafter.
In conclusion, the present case has been an uncommon
presentation of doxycycline-induced extensive ulcera-
tions, mimicking esophageal cancer in two esophageal
segments. A modification on the behavior of taking drugs
can prevent these unpleasant complications.
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